WallStSmart

Hinge Health, Inc. (HNGE)vsTempus AI, Inc. Class A Common Stock (TEM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tempus AI, Inc. Class A Common Stock generates 111% more annual revenue ($1.36B vs $646.34M). TEM leads profitability with a -22.2% profit margin vs -78.9%. HNGE earns a higher WallStSmart Score of 36/100 (F).

HNGE

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 3.5Value: 6.0Quality: 5.0
Piotroski: 3/9Altman Z: -2.71

TEM

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 4.0Quality: 5.5
Piotroski: 6/9Altman Z: -2.16
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HNGEUndervalued (+23.6%)

Margin of Safety

+23.6%

Fair Value

$50.74

Current Price

$56.02

$5.28 discount

UndervaluedFair: $50.74Overvalued
TEMSignificantly Overvalued (-59.9%)

Margin of Safety

-59.9%

Fair Value

$33.53

Current Price

$49.47

$15.94 premium

UndervaluedFair: $33.53Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HNGE2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.2%10/10

Revenue surging 47.2% year-over-year

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

TEM1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
36.1%10/10

Revenue surging 36.1% year-over-year

Areas to Watch

HNGE4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Price/BookValuation
39.5x2/10

Trading at 39.5x book value

Return on EquityProfitability
-136.0%2/10

ROE of -136.0% — below average capital efficiency

EPS GrowthGrowth
-94.4%2/10

Earnings declined 94.4%

TEM4 concerns · Avg: 3.0/10
Price/BookValuation
17.9x4/10

Trading at 17.9x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-81.6%2/10

ROE of -81.6% — below average capital efficiency

Free Cash FlowQuality
$-73.28M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : HNGE

The strongest argument for HNGE centers on Revenue Growth, Debt/Equity. Revenue growth of 47.2% demonstrates continued momentum.

Bull Case : TEM

The strongest argument for TEM centers on Revenue Growth. Revenue growth of 36.1% demonstrates continued momentum.

Bear Case : HNGE

The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.

Bear Case : TEM

The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.

Key Dynamics to Monitor

HNGE is growing revenue faster at 47.2% — sustainability is the question.

HNGE generates stronger free cash flow (43M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HNGE scores higher overall (36/100 vs 31/100) and 47.2% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hinge Health, Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.

Visit Website →

Tempus AI, Inc. Class A Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?